NICE final guidance recommends Lucentis® as cost-effective treatment for wet AMD, a leading cause of blindness

Wednesday, August 27, 2008

BASEL, Switzerland - The National Institute for Health and Clinical Excellence (NICE) has recommended Lucentis® (ranibizumab) as a cost-effective therapy for all eligible patients with wet age-related macular degeneration (AMD), an eye disease that is the leading cause of blindness in people over the age of 50....
Click the title to read the full article
Aug 27  »   NICE final guidance recommends Lucentis...

NICE final guidance recommends Lucentis® as cost-effective treatment for wet AMD, a leading cause of blindness

Wednesday, August 27, 2008

BASEL, Switzerland - The National Institute for Health and Clinical Excellence (NICE) has recommended Lucentis® (ranibizumab) as a cost-effective therapy for all eligible patients with wet age-related macular degeneration (AMD), an eye disease that is the leading cause of blindness in people over the age of 50....
Click the title to read the full article
Aug 27  »   Lonza introduces Clonetics® Adult...

Lonza introduces Clonetics® Adult Melanocytes for dermal research

Wednesday, August 27, 2008

BASEL, Switzerland / WALKERSVILLE – Lonza announces the availability of primary Clonetics® Adult Normal Human Epidermal Melanocytes. These are highlycharacterized cells for use in diverse applications in dermal research including malignant melanoma, dermal disorders, toxicology, pigmentation and cosmetic studies....
Click the title to read the full article
Aug 27  »   Glivec receives FDA priority review as...

Glivec receives FDA priority review as first therapy to reduce

Wednesday, August 27, 2008

BASEL, Switzerland - Novartis announced today that Glivec® (imatinib)* has been granted priority review status by the US Food and Drug Administration (FDA) as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors (GIST). ...
Click the title to read the full article
Aug 27  »   Agilent and its foundation extend...

Agilent and its foundation extend environmental education program in India

Wednesday, August 27, 2008

Agilent is committed to being an economic, intellectual and social asset to each nation and community in which it operates. As such, Agilent and its foundation support the efforts of the Clean Air Challenge (CAC) program to promote environmental sustainability through science education. Most recently, Agilent has helped extend this program in India....
Click the title to read the full...
Aug 27  »   Siegfried reports growth following...

Siegfried reports growth following consolidation process

Wednesday, August 27, 2008

The Siegfried Group (SWX: SFZN) announces sales in its continuing Divisions of CHF 318.3 million for the 2007 fiscal year, an increase of 6.2% over the previous year. Both Divisions of the Group improved their position and continued on their growth course. The EBITDA of the continued Divisions amounted to CHF 69 mil-lion, an increase over 2006 (CHF 66.4 million). Reported net income of CHF...
Aug 27  »   Thermo Fisher Scientific introduces cell...

Thermo Fisher Scientific introduces cell culture incubator portfolio

Wednesday, August 27, 2008

MILFORD, Mass., USA - Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Thermo Scientific HERAcell i Series of cell culture CO2 incubators....
Click the title to read the full article
Aug 27  »   DSM announces closure of its citric acid...

DSM announces closure of its citric acid manufacturing plant in Wuxi (China)

Wednesday, August 27, 2008

HEERLEN, The Netherlands - DSM N.V., the global Life Sciences and Materials Sciences Company headquartered in the Netherlands, today announces the closure of its citric acid manufacturing plant in Wuxi (China) by Q1 2009....
Click the title to read the full article
Aug 27  »   DSM invests in food ingredients developer...

DSM invests in food ingredients developer Provexis plc

Wednesday, August 27, 2008

HEERLEN, The Netherlands - DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announces that it has acquired an equity stake of 29.3% in Provexis plc, an AIM listed company that develops and licenses ingredients for the functional food, medical food and dietary supplement market. ...
Click the title to read the full article
Aug 26  »   Galapagos acquires structure-based drug...

Galapagos acquires structure-based drug discovery from Sareum

Tuesday, August 26, 2008

MECHELEN, Belgium and CAMBRIDGE, UK – Galapagos NV (Euronext: GLPG) and Sareum Holdings plc (AIM: SAR) announce today that Galapagos has acquired Sareum’s assets in drug discovery services, for a total cash consideration of €695,000 (£553,000). ...
Click the title to read the full article
Aug 26  »   Genzyme Corporation and Medicines for...

Genzyme Corporation and Medicines for Malaria Venture announce new collaboration with Advinus Therapeutics to accelerate discovery of novel therapies for malaria

Tuesday, August 26, 2008

Genzyme Corp. (Nasdaq: GENZ), a global leader in biotechnology, and Medicines for Malaria Venture (MMV), a not-for-profit virtual research and development (R&D) organization dedicated to reducing the burden of malaria, announced today a new collaboration with India’s Advinus Therapeutics Ltd. ...
Click the title to read the full article
Aug 26  »   Invitrogen sets date for special meeting...

Invitrogen sets date for special meeting of shareholders to vote on proposed merger with Applied Biosystems

Tuesday, August 26, 2008

CARLSBAD, CA, USA - Invitrogen Corporation (NASDAQ:IVGN) today announced it has set the date for a special meeting of its shareholders, to consider the proposed acquisition of Applied Biosystems Inc. ...
Click the title to read the full article
Aug 26  »   UPDATE 1-Actelion CEO says new use may...

UPDATE 1-Actelion CEO says new use may double Tracleer sales

Tuesday, August 26, 2008

BASEL, Switzerland, - Approval of Actelion Ltd's Tracleer for use in a fatal lung disease could double sales of its biggest drug, the biotech company's chief executive told Reuters....
Click the title to read the full article
Aug 26  »   Sucampo Pharmaceuticals appoints Kathryn...

Sucampo Pharmaceuticals appoints Kathryn de Santis as Vice President, Investor Relations and Corporate Communications

Tuesday, August 26, 2008

BETHESDA, MD, USA - Sucampo Pharmaceuticals, Inc., today announced that it has named Kathryn de Santis as its Vice President, Investor Relations and Corporate Communications....
Click the title to read the full article
Aug 26  »   'Swiss Army Drugs' present challenges

'Swiss Army Drugs' present challenges

Tuesday, August 26, 2008

Now a new class of so-called "Swiss Army Knife drugs" has emerged that treat an array of oft-unrelated ills. They include Centocor's Remicade, Abbott Labs' Humira, Pfizer's Lyrica, Amgen's Enbrel and Eli Lilly's Cymbalta. The same pill can treat conditions as varied as depression or diabetic nerve pain....
Click the title to read the full article
Aug 26  »   Roche's Tamiflu to safeguard businesses...

Roche's Tamiflu to safeguard businesses against a potential flu pandemic

Tuesday, August 26, 2008

CHICAGO, IL, USA - According to the CDC, an influenza pandemic could infect 30 percent of the overall American population -- that's 1,057,731 to 1,586,697 residents in Cook County alone. ...
Click the title to read the full article
Aug 26  »   Thermo Fisher Scientific to present at...

Thermo Fisher Scientific to present at Thomas Weisel Partners Healthcare Conference

Tuesday, August 26, 2008

WALTHAM, Mass., USA - Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will present at the Thomas Weisel Partners Healthcare Conference, being held at the Four Seasons Hotel in Boston. The company will present on Thursday, September 4, 2008, at 9:10 am (EDT)....
Click the title to read the full article
 
 
More news RSS

News

Add News Item Browse News News Categories

Events

Add Event Browse Events

Links

Add Link Browse Links

Newsletter

Subscribe a user Send a Newsletter

Staff

Add Staff Member Browse Staff Members Order Staff Members